$NTLA up over 8%

Intellia Therapeutics’ (NTLA) shares rose following the news that scientists at UC-Berkeley and Massachusetts General Hospital have found a way to improve the precision of DNA-editing technology CRISPR/Cas9.

Read the full post in our SeekingAlpha Marketplace Daily Pharma Scoop.